ADMA BIOLOGICS, INC. (ADMA) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $510.17M | +19.6% |
| 2024 | $426.45M | +65.2% |
| 2023 | $258.21M | +67.6% |
| 2022 | $154.08M | +90.4% |
| 2021 | $80.94M | +91.7% |
| 2020 | $42.22M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $510.17M | +19.6% |
| 2024 | $426.45M | +65.2% |
| 2023 | $258.21M | +67.6% |
| 2022 | $154.08M | +90.4% |
| 2021 | $80.94M | +91.7% |
| 2020 | $42.22M | — |